Beyond Chronological Age: Comorbidity Burden and Physiological Reserve Determine Survival After a Positive Screening Fecal Occult Blood Test in Older Adults

Every year, millions of people around the world face a silent threat: colorectal cancer. This disease often begins as small, harmless growths inside the colon that slowly turn into something dangerous over many years. Because these early changes rarely cause pain or other symptoms, doctors rely on simple screening tests to find them before they become a problem. One of the most common tools is a test that checks a stool sample for tiny, invisible traces of blood. If the test is positive, the usual next step is a colonoscopy, a procedure where a doctor uses a flexible tube to look inside the colon and remove any suspicious growths. For decades, medical guidelines have suggested that once people reach a certain age, usually around seventy-five, the risks of these procedures might outweigh the benefits. The logic was that older adults often have other health issues that shorten their lives, meaning they might not live long enough to benefit from finding a slow-growing cancer. However, this rule relies on a single number: the year a person was born. It treats all seventy-five-year-olds the same, ignoring the fact that some are frail and sick while others are robust and healthy.

A team of researchers in Thailand set out to see if this simple age-based rule makes sense for older adults. They looked back at the medical records of nearly seven hundred people who were at least seventy-five years old and had tested positive for hidden blood in their stool. These patients were being treated at a large university hospital in Bangkok. The researchers wanted to know two main things: first, how often did the colonoscopy actually find dangerous cancer or pre-cancerous growths in this older group? Second, and perhaps more importantly, what actually determined whether these patients lived or died over the next five years? Was it their age, or was it something else entirely? By following these patients carefully, the study aimed to replace the blunt instrument of chronological age with a more precise way of deciding who should undergo further testing.

The results revealed a striking reality. When the doctors performed colonoscopies on the patients who were healthy enough to undergo the procedure, they found significant problems in more than half of them. Specifically, they discovered colorectal cancer in about one in four patients and dangerous pre-cancerous growths in another one in four. This high rate of finding serious issues held true even for the oldest patients, those over eighty, and for those with many other health conditions. The procedure itself was remarkably safe; among the one hundred and sixty-two older adults who had the colonoscopy, there were no recorded complications such as bleeding or tears in the colon. This suggests that the screening test is still very effective at finding disease in people well past the traditional cutoff age, provided they are physically capable of handling the test.

However, finding the cancer was only half the story. The researchers then looked at who survived the next five years and who did not. They discovered that a person's birth year had very little to do with their fate. Instead, the strongest predictors of survival were the patient's overall health and their body's ability to recover from stress. The researchers used a scoring system that counted up a patient's various chronic illnesses, such as heart disease, kidney failure, and diabetes. They found that patients with a lower burden of these diseases had a five-year survival rate of nearly eighty-six percent. In contrast, those with a heavy burden of multiple serious illnesses had a survival rate of only about fifty percent. Similarly, a simple blood test measuring albumin, a protein that reflects the body's nutritional status and resistance to illness, proved to be a powerful indicator. Patients with higher levels of this protein lived significantly longer than those with lower levels.

The study also highlighted a difficult truth about screening in the very old. Even though the colonoscopy found cancer in many patients, the vast majority of deaths in this group were not caused by cancer. In fact, non-cancer deaths were more than seven times more common than deaths from colorectal cancer. Most of the patients who died passed away from their other existing health conditions, such as heart or kidney failure. This means that for many older adults, the primary threat to their life is not the cancer that might be found, but the other illnesses they already carry. The researchers noted that the patients who actually received the colonoscopy were a selected group; they were generally younger and healthier than those who did not get the procedure. This selection bias makes it hard to say for certain that the colonoscopy itself extended lives, but it does show that the procedure is safe and effective for those who are fit enough to have it.

Ultimately, this research suggests that the decision to screen for colorectal cancer in older adults should not be based on a calendar date. A seventy-five-year-old with a strong heart and good nutrition may have a much better chance of benefiting from screening than an eighty-year-old with multiple failing organs. The study argues that doctors should look at the whole person, considering their specific health conditions and their physical strength, rather than just their age. By focusing on these factors, medical teams can better identify which older adults are likely to live long enough to benefit from finding and treating cancer, and which might be better served by avoiding unnecessary procedures. This approach moves away from a one-size-fits-all rule and toward a more personalized strategy that respects the unique health journey of every older adult.